Dan L, Anthony F, Dennis K, Stephen H, Larry J, Joseph L, et al. Congenital heart disease in the Adult. Harrison’s Principles Intern Med. 2025;2067–2083.
Zikarg YT, Yirdaw CT, Aragie TG. Prevalence of congenital septal defects among congenital heart defect patients in East Africa: a systematic review and meta-analysis. PLoS ONE. 2021;16(4):e0250006. https://doi.org/10.1371/journal.pone.0250006.
Article CAS PubMed PubMed Central Google Scholar
Cunningham JW, Brown DW. Congenital Heart Disease. In: Lilly LS, editor. Pathophysiology of Heart Disease: An Introduction to Cardiovascular Medicine. 7th ed. Wolters Kluwer; 2024. p. 398–426.
Zimmerman MS, Smith AG, Sable CA, Echko MM, Wilner LB, Olsen HE, et al. Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Child & Adolesc Health. 2020;4(3):185–200.
Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol. 2019;48(2):455–63. https://doi.org/10.1093/ije/dyz009.
Article PubMed PubMed Central Google Scholar
Tanaka S, Imamura T, Narang N, Fukuda N, Ueno H, Kinugawa K. Practical therapeutic management of percutaneous atrial septal defect closure. Intern Med. 2022;61(1):15–22. https://doi.org/10.2169/internalmedicine.5944-20.
Xuan Tuan H, The Phuoc Long P, Duy Kien V, Manh Cuong L, Van Son N, Dalla-Pozza R. Trends in the prevalence of atrial septal defect and its associated factors among congenital heart disease patients in Vietnam. J Cardiovasc Dev Dis. 2019;7(1):2. https://doi.org/10.3390/jcdd7010002.
Article PubMed PubMed Central Google Scholar
Giang HTN, Hai TT, Nguyen H, Vuong TK, Morton LW, Culbertson CB. Elevated congenital heart disease birth prevalence rates found in Central Vietnam and dioxin TCDD residuals from the use of 2, 4, 5-T herbicides (Agent Orange) in the Da Nang region. PLOS Glob Public Health. 2022;2(10):e0001050. https://doi.org/10.1371/journal.pgph.0001050.
Article PubMed PubMed Central Google Scholar
Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, et al. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563–645. https://doi.org/10.1093/eurheartj/ehaa554.
Article CAS PubMed Google Scholar
El-Said HG, Bezold LI, Grifka RG, Pignatelli RH, McMahon CJ, Schutte DA, et al. Sizing of atrial septal defects to predict successful closure with transcatheter cardioSEAL device. Tex Heart Inst J. 2001;28(3):177–82.
CAS PubMed PubMed Central Google Scholar
Turner ME, Bouhout I, Petit CJ, Kalfa D. Transcatheter closure of atrial and ventricular septal defects: JACC focus seminar. J Am Coll Cardiol. 2022;79(22):2247–58. https://doi.org/10.1016/j.jacc.2021.08.082.
Patel KM, Desai RG, Trivedi K, Neuburger PJ, Krishnan S, Potestio CP. Complications of transesophageal echocardiography: a review of injuries, risk factors, and management. J Cardiothorac Vasc Anesth. 2022;36(8 Pt B):3292–302. https://doi.org/10.1053/j.jvca.2022.02.015.
Gupta SK, Sivasankaran S, Bijulal S, Tharakan JM, Harikrishnan S, Ajit K. Trans-catheter closure of atrial septal defect: balloon sizing or no balloon sizing - single centre experience. Ann Pediatr Cardiol. 2011;4(1):28–33. https://doi.org/10.4103/0974-2069.79619.
Article PubMed PubMed Central Google Scholar
Cao H, Chen Q, Zhang GC, Chen LW, Qiu ZH, Lu H. Percutaneous device closure of atrial septal defect with totally transthoracic echocardiography guide, without x-ray machine. Medicine (Baltimore). 2016;95(44):e5256. https://doi.org/10.1097/md.0000000000005256.
Xie LF, Lin Y, Chen MF, Zhang GC. Complete transthoracic echocardiography for the assessment and guidance of percutaneous atrial septal defect closure in adults without balloon sizing: an observed study with a 10-year follow-up. J Cardiovasc Dev Dis. 2023;10(8):321. https://doi.org/10.3390/jcdd10080321.
Article PubMed PubMed Central Google Scholar
Martinez MN, Bartholomew MJ. What does it “mean”? A review of interpreting and calculating different types of means and standard deviations. Pharmaceutics. 2017;9(2):14. https://doi.org/10.3390/pharmaceutics9020014.
Article CAS PubMed PubMed Central Google Scholar
Juzek TS, Kizach J. How to Set Delta in the two-one-sided T-tests procedure (TOST). J Res Design Stat Linguist Commun Sci. 2019;5(1–2):153–69. https://doi.org/10.1558/jrds.39002.
Meyners M. Equivalence tests – A review. Food Qual Prefer. 2012;26(2):231–45. https://doi.org/10.1016/j.foodqual.2012.05.003.
Mehta RH, Helmcke F, Nanda NC, Pinheiro L, Samdarshi TE, Shah VK. Uses and limitations of transthoracic echocardiography in the assessment of atrial septal defect in the adult. Am J Cardiol. 1991;67(4):288–94. https://doi.org/10.1016/0002-9149(91)90561-x.
Article CAS PubMed Google Scholar
Godart F, Rey C, Francart C, Jarrar M, Vaksmann G. Two-dimensional echocardiographic and color Doppler measurements of atrial septal defect, and comparison with the balloon-stretched diameter. Am J Cardiol. 1993;72(14):1095–7. https://doi.org/10.1016/0002-9149(93)90873-b.
Article CAS PubMed Google Scholar
Vesal A, Moradian M, Ghasemnezhad M, Tabib A, Rashidi Ghader F, Meraji SM, et al. Comparison between 2D transthoracic echocardiography, transesophageal echocardiography, and balloon sizing methods for device size selection in pediatric patients undergoing transcatheter closure of atrial septal defects. Iranian Heart J. 2022;23(1):74–84.
McGhie JS, van den Bosch AE, Haarman MG, Ren B, Roos-Hesselink JW, Witsenburg M, et al. Characterization of atrial septal defect by simultaneous multiplane two-dimensional echocardiography. Eur Heart J Cardiovasc Imaging. 2014;15(10):1145–51. https://doi.org/10.1093/ehjci/jeu098.
Saha SK, Ahmed CM, Haque T, Al Mamun MA, Hussain MZ. Assessment of atrial septal defects using 3-dimensional transthoracic echocardiography prior to percutaneous device closure: first report from Bangladesh. Ther Adv Cardiovasc Dis. 2023;17:17539447231193290. https://doi.org/10.1177/17539447231193290.
Article CAS PubMed PubMed Central Google Scholar
Hascoet S, Hadeed K, Marchal P, Dulac Y, Alacoque X, Heitz F, et al. The relation between atrial septal defect shape, diameter, and area using three-dimensional transoesophageal echocardiography and balloon sizing during percutaneous closure in children. Eur Heart J Cardiovasc Imaging. 2015;16(7):747–55. https://doi.org/10.1093/ehjci/jeu316.
Silvestry FE, Cohen MS, Armsby LB, Burkule NJ, Fleishman CE, Hijazi ZM, et al. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr. 2015;28(8):910–58. https://doi.org/10.1016/j.echo.2015.05.015.
Carlson KM, Justino H, O’Brien RE, Dimas VV, Leonard GT Jr., Pignatelli RH, et al. Transcatheter atrial septal defect closure: modified balloon sizing technique to avoid overstretching the defect and oversizing the Amplatzer septal occluder. Catheter Cardiovasc Interv. 2005;66(3):390–6. https://doi.org/10.1002/ccd.20443.
Quek SC, Wu WX, Chan KY, Ho TF, Yip WC. Transcatheter closure of atrial septal defects--is balloon sizing still necessary? Ann Acad Med Singap. 2010;39(5):390–3.
Rana BS. Echocardiography guidance of atrial septal defect closure. J Thorac Dis. 2018;10(Suppl 24):S2899–908. https://doi.org/10.21037/jtd.2018.07.126.
Article PubMed PubMed Central Google Scholar
Tzifa A, Gordon J, Tibby SM, Rosenthal E, Qureshi SA. Transcatheter atrial septal defect closure guided by colour flow Doppler. Int J Cardiol. 2011;149(3):299–303. https://doi.org/10.1016/j.ijcard.2010.01.014.
McElhinney DB, Quartermain MD, Kenny D, Alboliras E, Amin Z. Relative risk factors for cardiac erosion following transcatheter closure of atrial septal defects: a case-control study. Circulation. 2016;133(18):1738–46. https://doi.org/10.1161/circulationaha.115.019987.
Brida M, Chessa M, Celermajer D, Li W, Geva T, Khairy P, et al. Atrial septal defect in adulthood: a new paradigm for congenital heart disease. Eur Heart J. 2022;43(28):2660–71. https://doi.org/10.1093/eurheartj/ehab646.
Comments (0)